Westfield Capital Management CO LP Blueprint Medicines Corp Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $13.3 Million - $21.6 Million	-324,176 Reduced 40.34%	479,467 $21 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $29 Million - $45.2 Million	-581,167 Reduced 41.97%	803,643 $53 Million
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $9.56 Million - $14.8 Million	211,389 Added 18.01%	1,384,810 $69.9 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $4.04 Million - $8.23 Million	74,730 Added 6.8%	1,173,421 $75 Million
Q4 2021 Feb 10, 2022	SELL	$94.25 - $115.99 $11 Million - $13.5 Million	-116,662 Reduced 9.6%	1,098,691 $118 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $2.85 Million - $3.86 Million	35,234 Added 2.99%	1,215,353 $125 Million
Q2 2021 Aug 10, 2021	BUY	$82.78 - $101.0 $4.27 Million - $5.21 Million	51,632 Added 4.58%	1,180,119 $104 Million
Q1 2021 May 14, 2021	BUY	$90.71 - $108.28 $23.6 Million - $28.2 Million	260,420 Added 30.0%	1,128,487 $110 Million
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $17.7 Million - $24 Million	-192,731 Reduced 18.17%	868,067 $97.4 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $572,466 - $798,610	8,615 Added 0.82%	1,060,798 $98.3 Million
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $1.57 Million - $2.19 Million	27,576 Added 2.69%	1,052,183 $82.1 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $12.2 Million - $20.9 Million	253,971 Added 32.96%	1,024,607 $59.9 Million
Q4 2019 Feb 13, 2020	SELL	$66.73 - $82.59 $5.09 Million - $6.3 Million	-76,323 Reduced 9.01%	770,636 $61.7 Million
Q3 2019 Nov 08, 2019	BUY	$72.9 - $101.41 $17.1 Million - $23.8 Million	234,579 Added 38.31%	846,959 $62.2 Million
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $10.7 Million - $14.2 Million	145,339 Added 31.12%	612,380 $57.8 Million
Q1 2019 May 14, 2019	SELL	$48.7 - $86.6 $5.64 Million - $10 Million	-115,785 Reduced 19.87%	467,041 $37.4 Million
Q4 2018 Feb 08, 2019	BUY	$45.57 - $74.26 $3.35 Million - $5.45 Million	73,446 Added 14.42%	582,826 $31.4 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $17.5 Million - $23.2 Million	296,400 Added 139.17%	509,380 $39.8 Million
Q2 2018 Aug 13, 2018	BUY	$60.96 - $101.18 $13 Million - $21.5 Million	212,980 New	212,980 $13.5 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account